Zhujiang Hospital
Clinical trials sponsored by Zhujiang Hospital, explained in plain language.
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study tests whether two drugs, azacitidine and chidamide, can safely prevent high-risk acute myeloid leukemia from coming back after a stem cell transplant. About 20 adults aged 18-60 will receive this combination as maintenance therapy. The main goals are to check safety an…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Gut bacteria may supercharge lung cancer therapy
Disease control Recruiting nowThis study tests whether a daily probiotic called LR607 can make standard chemoimmunotherapy work better for people with stage IIB-IIIB non-small cell lung cancer that can be surgically removed. About 46 adults will take the probiotic for 3 months alongside their cancer treatment…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New combo therapy aims to stop liver Cancer's return in High-Risk patients
Disease control Recruiting nowThis study tests whether a treatment called TACE combined with the drug icaritin can help prevent liver cancer from returning after surgery in patients at high risk of recurrence. About 30 adults with hepatocellular carcinoma who had complete tumor removal will receive the combin…
Phase: PHASE2, PHASE3 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
New hope for anemia after leukemia transplant: drug trial launches
Disease control Recruiting nowThis study tests a drug called luspatercept to help people with acute leukemia who have anemia after a stem cell transplant. About 46 participants will receive two injections of the drug. The goal is to see if it safely raises hemoglobin levels and reduces the need for blood tran…
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
ICU kidney dialysis: which blood thinner dose works best?
Disease control Recruiting nowThis study looks at two different starting doses of a blood thinner called nafamostat in ICU patients who need continuous kidney dialysis. The goal is to see which dose keeps the dialysis filter working longer without causing dangerous bleeding. About 92 adults will be randomly a…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
AI takes on kidney biopsies: could it match expert pathologists?
Diagnosis Recruiting nowThis study is testing an artificial intelligence (AI) system that reads kidney biopsy images to help diagnose chronic kidney disease. About 2,900 people with suspected chronic kidney disease will have their biopsy images reviewed by both the AI and expert pathologists. The goal i…
Sponsor: Zhujiang Hospital • Aim: Diagnosis
Last updated May 06, 2026 16:02 UTC
-
Zap to awaken: new brain stimulation trial hopes to reach patients trapped in their minds
Symptom relief Recruiting nowThis study tests a new, non-invasive brain stimulation method called theta-burst patterned temporal interference stimulation (tTIs) to see if it can improve awareness in people with disorders of consciousness, such as vegetative or minimally conscious states. About 136 adults wil…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 07, 2026 12:17 UTC
-
New sedative may help ICU patients breathe on their own sooner
Symptom relief Recruiting nowThis study compares two sedative drugs, remimazolam and midazolam, in 440 critically ill adults who need a breathing machine in the ICU. The goal is to see if remimazolam helps patients come off the ventilator faster. Participants are randomly assigned to one of the two drugs, an…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 05, 2026 11:54 UTC
-
Ear zaps may spark awareness in Brain-Injured patients
Symptom relief Recruiting nowThis study tests a non-invasive technique called transcutaneous auricular vagus nerve stimulation (taVNS) in 20 people with disorders of consciousness, such as vegetative or minimally conscious states. Participants receive 20 sessions over 10 days. The goal is to see if this gent…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated May 04, 2026 16:30 UTC
-
Blood test may spot liver cancer return months before scans
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test that tracks cancer DNA (ctDNA) can predict if liver cancer will come back after surgery. Researchers will follow 255 adults who had their liver cancer removed and test their blood over time. The goal is to see if this test can find …
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 12:18 UTC
-
Mouth bacteria may predict cancer treatment success
Knowledge-focused Recruiting nowThis study tracks 32 people with advanced oral cancer to see how their mouth bacteria change after chemoimmunotherapy. Researchers want to know if these bacterial shifts relate to tumor shrinkage, drug resistance, or long-term survival. The goal is to find new ways to predict tre…
Sponsor: Zhujiang Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC